ClinicalTrials.gov
ClinicalTrials.gov Menu

EPT 100: Geranium Oil for the Relief of Neuropathic Pain (Geranium Oil)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01007747
Recruitment Status : Completed
First Posted : November 4, 2009
Last Update Posted : December 18, 2015
Sponsor:
Information provided by (Responsible Party):
Frank Greenway, Pennington Biomedical Research Center

Brief Summary:
The purpose of this study is to determine if Geranium oil will relieve a variety of neuropathic pain and some pain relief will last more than 48 hours.

Condition or disease Intervention/treatment Phase
Neuropathic Pain Other: Geranium oil Not Applicable

Detailed Description:
EPT 100 study is designed to identify the percentage of people who experience neuropathic pain relief from topical geranium oil from Reunion Island, determine which neuropathic pain conditions respond best and define the time course of the pain relief.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 166 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: EPT 100: Geranium Oil for the Relief of Neuropathic Pain
Study Start Date : November 2008
Actual Primary Completion Date : June 2011
Actual Study Completion Date : October 2011

Arm Intervention/treatment
Experimental: Geranium oil Other: Geranium oil
Daily topical application over neuropathic pain



Primary Outcome Measures :
  1. Pain relief [ Time Frame: 3 times in 30 to 60 minutes post-application ]

Secondary Outcome Measures :
  1. Response to therapy at 30 to 60 minutes, they will be asked to apply the oil to painful area daily [ Time Frame: Daily over 1 week ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 18 years of age or oler
  • Neuralgia or neuropathy with daily pain
  • At least moderate intensity pain
  • Signed informed consent

Exclusion Criteria:

  • Pregnant or nursing
  • Known allergies to geranium oil or geranium oil fractions

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01007747


Locations
United States, Louisiana
Pennington Biomedical Research Center
Baton Rouge, Louisiana, United States, 70808
Sponsors and Collaborators
Pennington Biomedical Research Center

Responsible Party: Frank Greenway, Clinical Medical Doctor, Pennington Biomedical Research Center
ClinicalTrials.gov Identifier: NCT01007747     History of Changes
Other Study ID Numbers: PBRC 21033
First Posted: November 4, 2009    Key Record Dates
Last Update Posted: December 18, 2015
Last Verified: December 2015

Keywords provided by Frank Greenway, Pennington Biomedical Research Center:
Geranium oil
Neuropathy

Additional relevant MeSH terms:
Neuralgia
Pain
Neurologic Manifestations
Nervous System Diseases
Peripheral Nervous System Diseases
Neuromuscular Diseases
Signs and Symptoms